ImmutriX Therapeutics
Manufacturing · South Dakota, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3620 Homestead St, Rapid City, South Dak...Phone Number
(605) 721-7979Website
www.immutrix.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About ImmutriX Therapeutics
ImmutriX Therapeutics, Inc. is a medical technology company based in Rapid City, South Dakota, specializing in innovative extracorporeal blood-filtration technologies. Their lead product is a proprietary hemoperfusion device that effectively removes harmful molecules from blood while preserving essential components, addressing urgent medical needs in emergency and intensive care settings. The company's technology targets specific immune response molecules to prevent complications and organ failure, positioning them as leaders in next-generation therapies. Their intended clients include healthcare providers and institutions dealing with acute and chronic medical conditions.Explore more
ImmutriX Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ImmutriX Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if ImmutriX Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when ImmutriX Therapeutics launches new products
Check if ImmutriX Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at ImmutriX Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if ImmutriX Therapeutics is spiking on competitors!
Earning: See what the market has to say on ImmutriX Therapeutics recently announced quarterly report
ImmutriX Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once ImmutriX Therapeutics has new funding data
Recommended Actions
Reach out to Masked Content who joined ImmutriX Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to ImmutriX Therapeutics
Compare insights from companies similar to ImmutriX Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ImmutriX Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ImmutriX Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ImmutriX Therapeutics.
ImmutriX Therapeutics financials insights
Gather financial insights about ImmutriX Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
2021
Debt
$187K
2025
Debt
$480K
ImmutriX Therapeutics Tech Stack
A closer look at the technologies used by ImmutriX Therapeutics
Most Recent Scoops
Funding
Funding
Funding
ImmutriX Therapeutics has received an SBA PPP loan in the amount of $187,104 from Pioneer Bank & Trust resulting in the retention of 14 jobs.
Funding
ImmutriX Therapeutics has received an SBA PPP loan for $150,000-350,000 from Pioneer Bank & Trust, supporting the retention of 14 jobs.
Funding
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ImmutriX Therapeutics
Sign Up For FreeTo access detailed company insights
ImmutriX Therapeutics, Inc. is a medical technology company based in Rapid City, South Dakota, specializing in innovative extracorporeal blood-filtration technologies. Their lead product is a proprietary hemoperfusion device that effectively removes harmful molecules from blood while preserving essential components, addressing urgent medical needs... Read More
